Cambridge Investment Research Advisors, Inc. - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 41 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2020$24,000
+41.2%
28,795
+2.2%
0.00%
Q2 2020$17,00028,1790.00%
Other shareholders

There were no reported owners of TONIX PHARMACEUTICALS HLDG C in Q4 2020.

NameSharesValueWeighting ↓
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders